InvestLog
STSS Sharps Technology, Inc. logo

STSS Sharps Technology, Inc.

Healthcare
$1.82+0.55%ClosedMarket Cap: $77.0M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.73

P/S

193.00

EV/EBITDA

-0.24

DCF Value

$0.41

FCF Yield

-264.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

-106.6%

Operating Margin

-3990.1%

Net Margin

-93391.3%

ROE

-166.4%

ROA

-204.8%

ROIC

-8.9%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$192.8K$-86.2M$—
Q4 null$-102.2K$-182.7M$—
FY null$204.1K$-282.5M$—
Q3 null$83.6K$-105.3M$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
FalconX Holdings Ltd10 percent owner
SellFri Feb 13
FalconX Holdings Ltd10 percent owner
SellFri Feb 13
FalconX Holdings Ltd10 percent owner
SellFri Feb 13
FalconX Holdings Ltd10 percent owner
SellFri Feb 13
FalconX Holdings Ltd10 percent owner
SellFri Feb 13

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

—

Beta

2.02

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Peers

CCLD logoCCLDCGTX logoCGTXGLSI logoGLSIIXHL logoIXHLJYNT logoJYNTLUCD logoLUCDMBOT logoMBOTPDEX logoPDEXRPID logoRPIDSERA logoSERA